Answers are grounded in this paper and cite their sources.
Haemolysis is commonly associated with the class of artemisinin drugs when used for the treatment of severe malaria. Potential causes of this safety issue are discussed. Although no deaths attributed to haemolysis have been reported so far, this safety issue may lead to life-threatening anaemia and is particularly worrying for regions where safe blood products are not readily available.
No takes yet. Share an insight, caveat, or question.
Rehman et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: